NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 603707 for the last quarter is 938.04 M CNY, and it's 17.21% lower compared to the previous quarter. The net income of Q3 24 is 200.77 M CNY.